Literature DB >> 25331901

Potential antigenic explanation for atypical H1N1 infections among middle-aged adults during the 2013-2014 influenza season.

Susanne L Linderman1, Benjamin S Chambers2, Seth J Zost2, Kaela Parkhouse3, Yang Li2, Christin Herrmann2, Ali H Ellebedy4, Donald M Carter5, Sarah F Andrews6, Nai-Ying Zheng6, Min Huang6, Yunping Huang6, Donna Strauss7, Beth H Shaz7, Richard L Hodinka8, Gustavo Reyes-Terán9, Ted M Ross5, Patrick C Wilson6, Rafi Ahmed4, Jesse D Bloom10, Scott E Hensley11.   

Abstract

Influenza viruses typically cause the most severe disease in children and elderly individuals. However, H1N1 viruses disproportionately affected middle-aged adults during the 2013-2014 influenza season. Although H1N1 viruses recently acquired several mutations in the hemagglutinin (HA) glycoprotein, classic serological tests used by surveillance laboratories indicate that these mutations do not change antigenic properties of the virus. Here, we show that one of these mutations is located in a region of HA targeted by antibodies elicited in many middle-aged adults. We find that over 42% of individuals born between 1965 and 1979 possess antibodies that recognize this region of HA. Our findings offer a possible antigenic explanation of why middle-aged adults were highly susceptible to H1N1 viruses during the 2013-2014 influenza season. Our data further suggest that a drifted H1N1 strain should be included in future influenza vaccines to potentially reduce morbidity and mortality in this age group.

Entities:  

Keywords:  antibody; antigenic drift; hemagglutinin; influenza; vaccine

Mesh:

Substances:

Year:  2014        PMID: 25331901      PMCID: PMC4226110          DOI: 10.1073/pnas.1409171111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  32 in total

1.  Structural basis of preexisting immunity to the 2009 H1N1 pandemic influenza virus.

Authors:  Rui Xu; Damian C Ekiert; Jens C Krause; Rong Hai; James E Crowe; Ian A Wilson
Journal:  Science       Date:  2010-03-25       Impact factor: 47.728

2.  Generation of live attenuated novel influenza virus A/California/7/09 (H1N1) vaccines with high yield in embryonated chicken eggs.

Authors:  Zhongying Chen; Weijia Wang; Helen Zhou; Amorsolo L Suguitan; Cindy Shambaugh; Lomi Kim; Jackie Zhao; George Kemble; Hong Jin
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Epitope-specific human influenza antibody repertoires diversify by B cell intraclonal sequence divergence and interclonal convergence.

Authors:  Jens C Krause; Tshidi Tsibane; Terrence M Tumpey; Chelsey J Huffman; Bryan S Briney; Scott A Smith; Christopher F Basler; James E Crowe
Journal:  J Immunol       Date:  2011-08-31       Impact factor: 5.422

4.  High intensive care unit admission rate for 2013-2014 influenza is associated with a low rate of vaccination.

Authors:  Jelena Catania; Loretta G Que; Joseph A Govert; John W Hollingsworth; Cameron R Wolfe
Journal:  Am J Respir Crit Care Med       Date:  2014-02-15       Impact factor: 21.405

5.  The antigenic structure of the influenza virus A/PR/8/34 hemagglutinin (H1 subtype).

Authors:  A J Caton; G G Brownlee; J W Yewdell; W Gerhard
Journal:  Cell       Date:  1982-12       Impact factor: 41.582

6.  Pandemic H1N1 influenza vaccine induces a recall response in humans that favors broadly cross-reactive memory B cells.

Authors:  Gui-Mei Li; Christopher Chiu; Jens Wrammert; Megan McCausland; Sarah F Andrews; Nai-Ying Zheng; Jane-Hwei Lee; Min Huang; Xinyan Qu; Srilatha Edupuganti; Mark Mulligan; Suman R Das; Jonathan W Yewdell; Aneesh K Mehta; Patrick C Wilson; Rafi Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

7.  Original antigenic sin responses to influenza viruses.

Authors:  Jin Hyang Kim; Ioanna Skountzou; Richard Compans; Joshy Jacob
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

8.  Neutralizing antibodies against previously encountered influenza virus strains increase over time: a longitudinal analysis.

Authors:  Matthew S Miller; Thomas J Gardner; Florian Krammer; Lauren C Aguado; Domenico Tortorella; Christopher F Basler; Peter Palese
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

9.  Epidemiologic and immunologic significance of age distribution of antibody to antigenic variants of influenza virus.

Authors:  F M DAVENPORT; A V HENNESSY; T FRANCIS
Journal:  J Exp Med       Date:  1953-12       Impact factor: 14.307

10.  Influenza-associated intensive-care unit admissions and deaths - California, September 29, 2013-January 18, 2014.

Authors:  Patrick Ayscue; Erin Murray; Timothy Uyeki; Jennifer Zipprich; Kathleen Harriman; Catheryn Salibay; Monica Kang; Annie Luu; Rose Glenn-Finer; James Watt; Carol Glaser; Janice Louie
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2014-02-21       Impact factor: 17.586

View more
  107 in total

Review 1.  Immune history and influenza virus susceptibility.

Authors:  Sarah Cobey; Scott E Hensley
Journal:  Curr Opin Virol       Date:  2017-01-12       Impact factor: 7.090

Review 2.  The evolution of seasonal influenza viruses.

Authors:  Velislava N Petrova; Colin A Russell
Journal:  Nat Rev Microbiol       Date:  2017-10-30       Impact factor: 60.633

3.  Design and Characterization of a Computationally Optimized Broadly Reactive Hemagglutinin Vaccine for H1N1 Influenza Viruses.

Authors:  Donald M Carter; Christopher A Darby; Bradford C Lefoley; Corey J Crevar; Timothy Alefantis; Raymond Oomen; Stephen F Anderson; Tod Strugnell; Guadalupe Cortés-Garcia; Thorsten U Vogel; Mark Parrington; Harold Kleanthous; Ted M Ross
Journal:  J Virol       Date:  2016-04-14       Impact factor: 5.103

4.  Immunodominance and Antigenic Variation of Influenza Virus Hemagglutinin: Implications for Design of Universal Vaccine Immunogens.

Authors:  Seth J Zost; Nicholas C Wu; Scott E Hensley; Ian A Wilson
Journal:  J Infect Dis       Date:  2019-04-08       Impact factor: 5.226

Review 5.  The evolution within us.

Authors:  Sarah Cobey; Patrick Wilson; Frederick A Matsen
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-05       Impact factor: 6.237

6.  Anomalous influenza seasonality in the United States and the emergence of novel influenza B viruses.

Authors:  Rebecca K Borchering; Christian E Gunning; Deven V Gokhale; K Bodie Weedop; Arash Saeidpour; Tobias S Brett; Pejman Rohani
Journal:  Proc Natl Acad Sci U S A       Date:  2021-02-02       Impact factor: 11.205

7.  Age-specific effects of vaccine egg adaptation and immune priming on A(H3N2) antibody responses following influenza vaccination.

Authors:  Feng Liu; F Liaini Gross; Stacie N Jefferson; Crystal Holiday; Yaohui Bai; Li Wang; Bin Zhou; Min Z Levine
Journal:  J Clin Invest       Date:  2021-04-15       Impact factor: 14.808

8.  Understanding immune responses to the influenza vaccine.

Authors:  Richard Webby
Journal:  Nat Med       Date:  2016-12-06       Impact factor: 53.440

9.  Influenza vaccination and the 'diversity paradox'.

Authors:  Craig P Thompson; Uri Obolski
Journal:  Hum Vaccin Immunother       Date:  2018-09-21       Impact factor: 3.452

Review 10.  From Original Antigenic Sin to the Universal Influenza Virus Vaccine.

Authors:  Carole Henry; Anna-Karin E Palm; Florian Krammer; Patrick C Wilson
Journal:  Trends Immunol       Date:  2017-08-31       Impact factor: 16.687

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.